v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2023 402,429        
Beginning balance at Dec. 31, 2023 $ 93,889        
Ending balance (in shares) at Mar. 31, 2024 402,429        
Ending balance at Mar. 31, 2024 $ 93,889        
Beginning balance (in shares) at Dec. 31, 2023   166,793      
Beginning balance at Dec. 31, 2023 (112,541) $ 0 $ 283,881 $ (396,408) $ (14)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 98   98    
Reporting currency translation adjustments 23       23
Net loss (6,594)     (6,594)  
Ending balance (in shares) at Mar. 31, 2024   166,793      
Ending balance at Mar. 31, 2024 $ (119,014) $ 0 283,979 (403,002) 9
Beginning balance (in shares) at Dec. 31, 2023 402,429        
Beginning balance at Dec. 31, 2023 $ 93,889        
Ending balance (in shares) at Jun. 30, 2024 402,429        
Ending balance at Jun. 30, 2024 $ 93,889        
Beginning balance (in shares) at Dec. 31, 2023   166,793      
Beginning balance at Dec. 31, 2023 (112,541) $ 0 283,881 (396,408) (14)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Reporting currency translation adjustments 27        
Net loss (65,526)        
Ending balance (in shares) at Jun. 30, 2024   166,793      
Ending balance at Jun. 30, 2024 $ (177,845) $ 0 284,076 (461,934) 13
Beginning balance (in shares) at Mar. 31, 2024 402,429        
Beginning balance at Mar. 31, 2024 $ 93,889        
Ending balance (in shares) at Jun. 30, 2024 402,429        
Ending balance at Jun. 30, 2024 $ 93,889        
Beginning balance (in shares) at Mar. 31, 2024   166,793      
Beginning balance at Mar. 31, 2024 (119,014) $ 0 283,979 (403,002) 9
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 97   97    
Reporting currency translation adjustments 4       4
Net loss (58,932)     (58,932)  
Ending balance (in shares) at Jun. 30, 2024   166,793      
Ending balance at Jun. 30, 2024 $ (177,845) $ 0 284,076 (461,934) 13
Beginning balance (in shares) at Dec. 31, 2024 1,714,792 1,714,792      
Beginning balance at Dec. 31, 2024 $ (8,610) $ 0 453,172 (461,801) 19
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for common stock purchase agreement (in shares) [1]   342,842      
Issuance of common stock for restricted stock units vesting (in shares)   4,145      
Stock-based compensation expense 2,131   2,131    
Reporting currency translation adjustments 2       2
Net loss (5,959)     (5,959)  
Ending balance (in shares) at Mar. 31, 2025   2,061,779      
Ending balance at Mar. 31, 2025 $ (12,436) $ 0 455,303 (467,760) 21
Beginning balance (in shares) at Dec. 31, 2024 1,714,792 1,714,792      
Beginning balance at Dec. 31, 2024 $ (8,610) $ 0 453,172 (461,801) 19
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Reporting currency translation adjustments 7        
Net loss $ (10,542)        
Ending balance (in shares) at Jun. 30, 2025 2,061,779 2,061,779      
Ending balance at Jun. 30, 2025 $ (15,160) $ 0 457,157 (472,343) 26
Beginning balance (in shares) at Mar. 31, 2025   2,061,779      
Beginning balance at Mar. 31, 2025 (12,436) $ 0 455,303 (467,760) 21
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for common stock purchase agreement [1] 540   540    
Transaction costs for common stock issuance (249)   (249)    
Stock-based compensation expense 1,563   1,563    
Reporting currency translation adjustments 5       5
Net loss $ (4,583)     (4,583)  
Ending balance (in shares) at Jun. 30, 2025 2,061,779 2,061,779      
Ending balance at Jun. 30, 2025 $ (15,160) $ 0 $ 457,157 $ (472,343) $ 26
[1] See Note 8 - Common Stock and Stock-based Compensation for more information on the common stock purchase agreement